195 related articles for article (PubMed ID: 23363271)
21. Cyclin D1 as a universally expressed mantle cell lymphoma-associated tumor antigen for immunotherapy.
Wang M; Sun L; Qian J; Han X; Zhang L; Lin P; Cai Z; Yi Q
Leukemia; 2009 Jul; 23(7):1320-8. PubMed ID: 19225534
[TBL] [Abstract][Full Text] [Related]
22. Mantle cell lymphoma: 2015 update on diagnosis, risk-stratification, and clinical management.
Vose JM
Am J Hematol; 2015 Aug; 90(8):739-45. PubMed ID: 26103436
[TBL] [Abstract][Full Text] [Related]
23. Mantle cell lymphoma: biology, pathogenesis, and the molecular basis of treatment in the genomic era.
Pérez-Galán P; Dreyling M; Wiestner A
Blood; 2011 Jan; 117(1):26-38. PubMed ID: 20940415
[TBL] [Abstract][Full Text] [Related]
24. Current treatment standards and emerging strategies in mantle cell lymphoma.
Dreyling M; Hiddemann W;
Hematology Am Soc Hematol Educ Program; 2009; ():542-51. PubMed ID: 20008239
[TBL] [Abstract][Full Text] [Related]
25. Mantle cell lymphoma: A clinical review of the changing treatment paradigms with the advent of novel therapies, and an insight into Indian data.
Radhakrishnan VS; Lokireddy P; Parihar M; Prakash PS; Menon H
Cancer Rep (Hoboken); 2022 Jul; 5(7):e1590. PubMed ID: 34821081
[TBL] [Abstract][Full Text] [Related]
26. Molecular profiling and management of mantle cell lymphoma.
Ruan J
Hematology Am Soc Hematol Educ Program; 2019 Dec; 2019(1):30-40. PubMed ID: 31808882
[TBL] [Abstract][Full Text] [Related]
27. Mantle cell lymphoma: state-of-the-art management and future perspective.
Weigert O; Unterhalt M; Hiddemann W; Dreyling M
Leuk Lymphoma; 2009 Dec; 50(12):1937-50. PubMed ID: 19863180
[TBL] [Abstract][Full Text] [Related]
28. The molecular pathogenesis of mantle cell lymphoma.
Vogt N; Dai B; Erdmann T; Berdel WE; Lenz G
Leuk Lymphoma; 2017 Jul; 58(7):1530-1537. PubMed ID: 27894215
[TBL] [Abstract][Full Text] [Related]
29. Characterization of 4 mantle cell lymphoma cell lines.
Amin HM; McDonnell TJ; Medeiros LJ; Rassidakis GZ; Leventaki V; O'Connor SL; Keating MJ; Lai R
Arch Pathol Lab Med; 2003 Apr; 127(4):424-31. PubMed ID: 12683869
[TBL] [Abstract][Full Text] [Related]
30. Mantle cell lymphoma: recent insights into pathogenesis, clinical variability, and new diagnostic markers.
Sander B
Semin Diagn Pathol; 2011 Aug; 28(3):245-55. PubMed ID: 21850989
[TBL] [Abstract][Full Text] [Related]
31. Mantle cell lymphoma in the era of precision medicine-diagnosis, biomarkers and therapeutic agents.
Inamdar AA; Goy A; Ayoub NM; Attia C; Oton L; Taruvai V; Costales M; Lin YT; Pecora A; Suh KS
Oncotarget; 2016 Jul; 7(30):48692-48731. PubMed ID: 27119356
[TBL] [Abstract][Full Text] [Related]
32. Significance of cyclin D1 overexpression for the diagnosis of mantle cell lymphoma: a clinicopathologic comparison of cyclin D1-positive MCL and cyclin D1-negative MCL-like B-cell lymphoma.
Yatabe Y; Suzuki R; Tobinai K; Matsuno Y; Ichinohasama R; Okamoto M; Yamaguchi M; Tamaru J; Uike N; Hashimoto Y; Morishima Y; Suchi T; Seto M; Nakamura S
Blood; 2000 Apr; 95(7):2253-61. PubMed ID: 10733493
[TBL] [Abstract][Full Text] [Related]
33. Mantle cell lymphoma: 2012 update on diagnosis, risk-stratification, and clinical management.
Vose JM
Am J Hematol; 2012 Jun; 87(6):604-9. PubMed ID: 22615102
[TBL] [Abstract][Full Text] [Related]
34. Indolent mantle cell lymphoma.
Hsi ED; Martin P
Leuk Lymphoma; 2014 Apr; 55(4):761-7. PubMed ID: 23927395
[TBL] [Abstract][Full Text] [Related]
35. Mantle cell lymphoma--a spectrum from indolent to aggressive disease.
Sander B; Quintanilla-Martinez L; Ott G; Xerri L; Kuzu I; Chan JK; Swerdlow SH; Campo E
Virchows Arch; 2016 Mar; 468(3):245-57. PubMed ID: 26298543
[TBL] [Abstract][Full Text] [Related]
36. Should there be a standard therapy for mantle cell lymphoma?
Smith MR
Future Oncol; 2011 Feb; 7(2):227-37. PubMed ID: 21345142
[TBL] [Abstract][Full Text] [Related]
37. Mantle cell lymphoma: 2013 Update on diagnosis, risk-stratification, and clinical management.
Vose JM
Am J Hematol; 2013 Dec; 88(12):1082-8. PubMed ID: 24273091
[TBL] [Abstract][Full Text] [Related]
38. Personalized approaches for treatment-naïve mantle cell lymphoma.
Qualls D; Kumar A
Expert Rev Hematol; 2023 Feb; 16(2):95-107. PubMed ID: 36748785
[TBL] [Abstract][Full Text] [Related]
39. Advances in the understanding of mantle cell lymphoma.
Jares P; Campo E
Br J Haematol; 2008 Jun; 142(2):149-65. PubMed ID: 18410453
[TBL] [Abstract][Full Text] [Related]
40. Mantle cell lymphoma: state of the art.
Skarbnik AP; Goy AH
Clin Adv Hematol Oncol; 2015 Jan; 13(1):44-55. PubMed ID: 25679973
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]